Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors

[In The News]

Mr. Buchalter brings over thirty years' experience in the biopharmaceutical industry, with strong corporate leadership and an extensive background in the commercial positioning and development of therapeutics in oncology SINGAPORE, Feb. 28, 2019 /PRNewswire/ -- Tessa Therapeutics, a...

View the full article